H2020HORIZONFP7
Oslo Universitetssykehus Hf
- Country
- NONorway
- Defence projects
- 0
- Projects, all programmes
- 111
- As coordinator
- 19
- EU contribution (CORDIS)
- EUR 51,564,813
- Active
- 2008 to 2026
Projects
111 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| TEARFThe Effect of Alpha emitters and Radiofrequency Fields on cancer cells in culture. | HORIZON | 2026 | Associated partner | Not stated |
| AMAZING-6GAmazing Large-Scale Trials and Pilots for Verticals in 6G | HORIZON | 2025 | Participant | EUR 486,000 |
| OPTIPATHADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY | HORIZON | 2025 | Third party | Not stated |
| FatVersusBileFatty liver versus autoimmunity of the bile ducts - defining the gut signals driving steatosis and inflammatory disease of the gut-liver axis | HORIZON | 2025 | Participant | EUR 511,320 |
| PanCare4AYAPatient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer | HORIZON | 2025 | Participant | Not stated |
| CANDLENational CAncer data Node DeveLopErs | HORIZON | 2025 | Participant | EUR 35,938 |
| SCALPELSpecific Conjugation of Antibodies to Lipid Photo-peroxidised cancer tissues for their immunogenic ELimination | HORIZON | 2025 | Coordinator | EUR 1,807,831 |
| CHRONOSAccurate quantification of neurologic disease over time | HORIZON | 2025 | Coordinator | EUR 150,000 |
| PREDI-LYNCHValidated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome | HORIZON | 2025 | Coordinator | EUR 2,303,391 |
| IMProGlycoInhibitor-Mediated Programming of Glycoforms | HORIZON | 2025 | Participant | EUR 78,349 |
| Mac4MeMacrophage Targets for Metastatic Treatment | HORIZON | 2024 | Participant | EUR 297,749 |
| GLIOMATCHThe malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics | HORIZON | 2024 | Participant | EUR 1,069,080 |
| NuCapCureDevelopment of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis. | HORIZON | 2024 | Third party | Not stated |
| FluiDx-ADA novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's Disease | HORIZON | 2024 | Coordinator | EUR 1,158,125 |
| HoloSurgeMultimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers | HORIZON | 2024 | Participant | EUR 938,339 |
| ENT1DEPENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION | HORIZON | 2024 | Participant | EUR 638,040 |
| e-QuoLe-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia | HORIZON | 2024 | Participant | EUR 84,304 |
| REFINEFrom solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels | HORIZON | 2023 | Participant | EUR 525,200 |
| EUonQoLQuality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe | HORIZON | 2023 | Participant | EUR 749,375 |
| TTT-therapyTargeting Acute Leukemia with TdT-TCR-T-cell therapy | HORIZON | 2023 | Coordinator | EUR 20,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.